Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126939331 | 12693933 | 1 | I | 2005 | 20160127 | 20160829 | 20160829 | EXP | CA-PFIZER INC-2016051829 | PFIZER | 44.00 | YR | F | Y | 0.00000 | 20160829 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126939331 | 12693933 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, 2X/WEEK | N | 0 | 25 | MG | BIW | ||||||
| 126939331 | 12693933 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 25 MG, UNK | 11719 | 25 | MG | ||||||||
| 126939331 | 12693933 | 3 | SS | ORENCIA | ABATACEPT | 1 | 1000 MG, EVERY 4 WEEKS | N | 0 | 1000 | MG | ||||||||
| 126939331 | 12693933 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, 1X/DAY | N | 0 | 20 | MG | TABLET | QD | ||||||
| 126939331 | 12693933 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, EVERY 2 WEEKS | N | 0 | 40 | MG | |||||||
| 126939331 | 12693933 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, UNK | N | 0 | 40 | MG | |||||||
| 126939331 | 12693933 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | 40 MG, CYCLIC | N | 0 | 40 | MG | ||||||||
| 126939331 | 12693933 | 8 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, 1X/DAY | 0 | 400 | MG | TABLET | QD | |||||||
| 126939331 | 12693933 | 9 | C | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 1000 MG, UNK | 0 | 1000 | MG | ||||||||
| 126939331 | 12693933 | 10 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 126939331 | 12693933 | 11 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | UNK | 0 | |||||||||||
| 126939331 | 12693933 | 12 | C | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126939331 | 12693933 | 1 | Rheumatoid arthritis |
| 126939331 | 12693933 | 3 | Rheumatoid arthritis |
| 126939331 | 12693933 | 4 | Rheumatoid arthritis |
| 126939331 | 12693933 | 5 | Rheumatoid arthritis |
| 126939331 | 12693933 | 8 | Rheumatoid arthritis |
| 126939331 | 12693933 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126939331 | 12693933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126939331 | 12693933 | Drug ineffective | |
| 126939331 | 12693933 | Foot deformity | |
| 126939331 | 12693933 | Gait disturbance | |
| 126939331 | 12693933 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126939331 | 12693933 | 1 | 200502 | 200512 | 0 | |
| 126939331 | 12693933 | 2 | 200410 | 0 | ||
| 126939331 | 12693933 | 3 | 200811 | 200908 | 0 | |
| 126939331 | 12693933 | 4 | 200206 | 200410 | 0 | |
| 126939331 | 12693933 | 5 | 200510 | 2007 | 0 | |
| 126939331 | 12693933 | 6 | 200909 | 20160126 | 0 | |
| 126939331 | 12693933 | 7 | 2016 | 2016 | 0 | |
| 126939331 | 12693933 | 8 | 2004 | 0 | ||
| 126939331 | 12693933 | 9 | 200802 | 0 |